In keeping with these findings, studies in mouse AMI models which circumvent senescence in fibroblasts by genetic manipulation of p53 or p53‐stabilizing proteins results in reduced accumulation of senescent cells but increased infarct size, increased fibrosis and increased mortality 28 days post‐MI. Here, TP53 is linked to myocardial infarction.